Selected article for: "OD optical density and optical density"

Author: Ahn, Jin Young; Sohn, Yujin; Lee, Su Hwan; Cho, Yunsuk; Hyun, Jong Hoon; Baek, Yae Jee; Jeong, Su Jin; Kim, Jung Ho; Ku, Nam Su; Yeom, Joon-Sup; Roh, Juhye; Ahn, Mi Young; Chin, Bum Sik; Kim, Young Sam; Lee, Hyukmin; Yong, Dongeun; Kim, Hyun Ok; Kim, Sinyoung; Choi, Jun Yong
Title: Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea
  • Document date: 2020_4_6
  • ID: 1uwir5b8_6
    Snippet: On day 9, the arterial blood gas analysis showed PaO 2 /FiO 2 of 86, consistent with severe ARDS. Intravenous methylprednisolone (1 mg/kg/day daily) was started. On day 10, convalescent plasma was obtained from a male donor in his 20s who had recovered from COVID-19 for 21 days. He was diagnosed as COVID-19 presenting fever, cough and pneumonia, however, showed complete recovery and didn't have any symptom at the time of plasma donation. He has m.....
    Document: On day 9, the arterial blood gas analysis showed PaO 2 /FiO 2 of 86, consistent with severe ARDS. Intravenous methylprednisolone (1 mg/kg/day daily) was started. On day 10, convalescent plasma was obtained from a male donor in his 20s who had recovered from COVID-19 for 21 days. He was diagnosed as COVID-19 presenting fever, cough and pneumonia, however, showed complete recovery and didn't have any symptom at the time of plasma donation. He has met the blood donor eligibility criteria for plasma donation, including age, weight, reasonable-sized antecubital veins. Also, allogeneic donor screening tests, defined by enforcement rules of the Blood Management Act in Korea, were acceptable for transfusion. Donor apheresis was performed with Spectra Optia apheresis system (CMNC software; Spectra Optia IDL Tubing set; Terumo BCT, Lakewood, CO, USA), 500 mL of convalescent plasma was collected. Anti-SARS-CoV-2 IgG antibody in plasma was measured by enzyme-linked immunosorbent assay (ELISA) (Novel Coronavirus COVID-19 IgG ELISA kit; Epitope Diagnostics, San Diego, CA, USA) and optical density (OD) ratio for IgG was 0.586 (cut-off value 0.22). The plasma was divided into two doses and administered to the patient at 12 hours interval. Each dose was given over for 1 hour. No adverse reaction occurred after the administration of convalescent plasma.

    Search related documents:
    Co phrase search for related documents
    • adverse reaction and blood donor: 1
    • adverse reaction and complete recovery: 1, 2
    • adverse reaction and convalescent plasma: 1, 2, 3, 4, 5, 6, 7
    • adverse reaction and cut value: 1
    • adverse reaction and donor screening: 1
    • adverse reaction and IgG ratio: 1
    • adverse reaction and intravenous methylprednisolone: 1
    • adverse reaction and male donor: 1
    • adverse reaction and OD IgG ratio: 1
    • adverse reaction and pneumonia cough: 1
    • adverse reaction and present fever: 1, 2
    • adverse reaction and weight age: 1, 2
    • Anti SARS and blood donor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • Anti SARS and blood gas: 1
    • Anti SARS and complete recovery: 1, 2, 3, 4, 5
    • Anti SARS and convalescent plasma: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • Anti SARS and convalescent plasma administration: 1, 2, 3, 4, 5, 6
    • Anti SARS and cut value: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • Anti SARS and donor screening: 1, 2, 3